Please Wait.....
Report
Global Gene Editing Technology Business and Investment Opportunities - Analysis and Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update
Market Report I 2023-08-10 I 1300 Pages I BioIntel360
Insights and data in the report has been segmented under the following six modules:
Module 1: Global Gene Editing Funding and Investments Outlook
This module provides insights and data related to gene editing partnerships and investment (research and development, mergers and acquisitions, product development, commercialization, licensing, and manufacturing) and allows a peek into the futuristic trends of gene editing technology investment area.
Module 2: Global Gene Editing Clinical Trial Data Assessment
This module evaluates the data available from clinical trials conducted for various CRISPR, ZFNs, TALENs, and meganucleases-based therapies, representing a bird's eye view of emerging market dynamics and risks in the gene editing sector.
Module 3: Global Gene Editing Patent Data Analysis
This module presents an exhaustive study of gene editing patent analytics (CRISPR, ZFN, TALENs, and meganucleases) at various levels, including strategic research planning as well as analyzing their potential applications.
Module 4: Competitive Landscape
This module provides detailed information along with a scoring matrix of key companies related to the gene editing industry, including their historical performance and the latest developments.
Module 5: Global Gene Editing Market Size and Forecast
This module provides projections on the market's development during the years 2018-2027 after the profound evaluation of market dynamics at the deeper segmentation level. This report also provides an in-depth, data-centric analysis of the global gene editing market at regional and country levels:
By Technology
- CRISPR CAS 9
- TALENs
- ZFN
- Others (Meganucleases)
By Products
- Kits & Enzymes (By CRISPR, TALENs, ZFN, Meganucleases)
- Cell lines & Antibodies (By CRISPR, TALENs, ZFN, Meganucleases)
- Plasmid & Controls (By CRISPR, TALENs, ZFN, Meganucleases)
By Delivery Method
- Ex-vivo
- In-vivo
By Disease/Disorders
- Cancer
- Blood Disorders (beta-thalassemia and sickle cell disease)
- Blindness
- Respiratory Disease (COVID-19 & Cystic fibrosis)
- Others (AIDS, Huntington's disease, Muscular dystrophy)
By Application
- Drug Development
- Diagnostics
- Plant Gene Editing
- Others (Animal Gene Editing)
By End-User
- Pharmaceutical and Biopharmaceutical Companies
- Biotechnology Companies
- Contract Research Organisations
- Academic Institutes and Research Centres
By Regions
- North America
- U. S
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Germany
- Italy
- Switzerland
- Asia-Pacific
- China
- Japan
- Australia
- India
- South Korea
- MEA region
- Israel
- South Africa
- Turkey
- U.A. E
- Saudi Arabia
- Latin America
- Brazil
- Argentina
Key Companies Covered
- bluebird bio
- Beam Therapeutics
- Caribou Biosciences
- Cellectis
- Allogene Therapeutics
- Intellia Therapeutics
- Editas Medicine
- Verve Therapeutics
- AstraZeneca
- Merck KGaA
- Thermo Fisher Scientific
Module 6 Regulatory Outlook
This module contains a detailed understanding of the ethical, legal, and social implications of gene editing technology.
This market intelligence report features an in-depth analysis on the current market dynamics of gene editing technologies such as CRISPR/Cas9, ZFNs, TALENs, and Meganucleases.
It provides a detailed analysis of gene editing market dynamics, covering clinical trials, patent data, financial deals, and competitive landscape through 40+ sections, 1091 tables, and 1467 charts.
Chapter: 1 About this Report
1.1 Research Methodology
1.2 Definitions
1.3 Disclaimer
Chapter: 2 Gene Editing Market Dynamics
2.1 Introduction
2.2 Global Gene Editing Technology Market Outlook and Future Growth Dynamics
2.2.1 Market Opportunities and Growth Dynamics
2.2.2 Strategy and Innovations
2.2.3 Regulation and Challenges Related to Gene Editing Around the Globe
2.3 Regulatory Dynamics Assessment Across Different regions
2.3.1 North America Gene Editing Regulations
2.3.2 Europe Gene Editing Regulations
2.3.3 Asia Pacific Gene Editing Regulations
2.3.4 Middle East & Africa region Gene Editing Regulation
2.3.5 Latin America Gene Editing Regulations
Chapter: 3 Global Gene Editing Technology Discovery and Clinical Pipeline Market Attractiveness
3.1 CRISPR Based: Discovery and Clinical Pipeline
3.2 TALEN Based: Discovery and Clinical Pipeline
3.3 ZFNs Based: Discovery and Clinical Pipeline
3.4 Meganucleases Based: Discovery and Clinical Pipeline
Chapter: 4 Gene Editing Technology Financial Deals & Alliances: Analysis of Emerging Market Dynamics & Outlook, 2018-2027
4.1 Gene Editing Technology Financial Deals Market Size and Forecast, 2018-2027
4.2 Gene Editing Technology Financial Deals Vs Mergers & Acquisition, 2021 vs 2024
4.3 Gene Editing Technology Financial Deals Analysis by Application, 2021 vs 2024
4.4 Gene Editing Technology Financial Deals Analysis by Diseases, 2021 vs 2024
4.5 Gene Editing Technology Financial Deals Analysis by Region, 2021 vs 2024
4.6 Gene Editing Financial Deals Analysis by Type of Technology, 2021 vs 2024
4.7 Gene Editing Technology Financial Deals Analysis by End-Use Sector, 2021 vs 2024
4.8 Gene Editing Technology Financial Deals by Fundings and Investment
4.8.1 Gene Editing Technology Funding and Investment Annual Analysis, 2018-2027
4.8.2 Gene Editing Technology Funding and Investment by Year, Growth Rate (%)
4.8.3 Gene Editing Technology Funding Analysis by Geographical Regions
4.8.4 Gene Editing Technology: Funding Analysis by Type of Industry Players
4.8.5 Gene Editing Technology: Funding Analysis by Therapeutics
4.8.6 Gene Editing Technology Type of Funding Analysis
4.9 Key Financial Deals & Alliances - Recent List of Major Acquisition and Mergers
4.10 North America Region Financial Deals
4.11 Europe Region Financial Deals
Chapter: 5 Gene Editing Technology Patent Analysis & Outlook
5.1 Gene Editing Technology Patent Analysis & Outlook, 2018-2027
5.2 Gene Editing Technology: Patent Players Overview
5.3 Gene Editing Technology: White Space Mapping Analysis
5.4 Gene Editing Technology: Keyword Search Expressions
5.5 Gene Editing Technology: Type of Innovation Analysis
5.6 Gene Editing Technology: Type of Innovation Futuristic Analysis
5.7 Gene Editing Technology: CRISPR Top Patent Owners Benchmarking Analysis
5.8 Gene Editing Technology: TALENs Top Patent Owners Benchmarking Analysis
5.9 Gene Editing Technology: ZFNs Top Patent Owners Benchmarking Analysis
5.10 Gene Editing Technology: Patent Valuation Analysis
5.11 Gene Editing Technology: Scope of Innovation Analysis
5.12 Gene Editing Technology Scope of Innovation FTO Analysis
5.13 Trends Associated with Legal Status: Gene Editing Technology
5.14 Patent Filing Velocity Analysis: Gene Editing Technology
5.15 Trends Associated with Investors: Gene Editing Technology
5.16 Trends Associated with Top Applicants: Gene Editing Technology
5.17 CPC Code Classification Analysis of Patents by Type of Gene Editing Technology
5.18 Geographical Distribution of Patents by Type of Gene Editing Technology
5.19 Key Recent Patents by Gene Editing Technology
Chapter: 6 Clinical Trial Analysis & Outlook, 2017-2027
6.1 Global Gene Editing Technology: Clinical Trial Region-wise Prediction & Estimation, 2018-2027
6.2 Clinical Trial Analysis by Key Countries
6.3 Clinical Trial Analysis by Disease / Disorder
6.4 Gene Editing Technology Clinical Trial Phase-wise Analysis
6.5 Gene Editing Technology Clinical Trial Status Analysis
6.6 Gene Editing Technology Clinical Trial Study-type Analysis
6.7 Snapshot of Key Clinical Trials
Chapter: 7 Gene Editing Technology Competitive Landscape Analysis: Key Company Profiles and Strategic Initiatives
7.1 Gene Editing Competitive Index Ranking & Attractiveness Quadrant
7.2 Gene Editing Technology: Competitive Analysis Quadrant
7.3 Gene Editing Competitive Landscape by End Markets
7.4 Key Companies by Regions
7.5 Competitive Landscape by Type of Gene Editing Technology
7.6 Company Profiling
7.7 CRISPR Therapeutics AG
7.8 bluebird bio
7.9 Beam Therapeutics
7.10 Caribou Biosciences
7.11 Cellectis
7.12 Allogene Therapeutics
7.13 Intellia Therapeutics Inc.
7.14 Editas Medicine
7.15 Verve Therapeutics
7.16 AstraZeneca
7.17 Merck KGaA
7.18 Thermo Fisher Scientific Inc.
Chapter: 8 Gene Editing Technology Market Size and Forecast, 2018-2027
8.1 Gene Editing Technology Market Share by Technology (%), 2018-2027
8.1.1 Gene Editing Technology Market Size and Forecast by CRISPR, 2018-2027
8.1.2 Gene Editing Technology Market Size and Forecast by TALENs, 2018-2027
8.1.3 Gene Editing Technology Market Size and Forecast by ZFNs, 2018-2027
8.1.4 Gene Editing Technology Market Size and Forecast by Meganucleases, 2018-2027
8.2 Gene Editing Technology Market Share by CRISPR Product (%), 2018-2027
8.2.1 Gene Editing Technology Market Size and Forecast by Vector Based Cas9, 2018-2027
8.2.2 Gene Editing Technology Market Size and Forecast by DNA Free Cas9, 2018-2027
8.2.3 Gene Editing Technology Market Size and Forecast by Libraries & Antibodies, 2018-2027
8.2.4 Gene Editing Technology Market Size and Forecast by gRNA Design and Vector Construction, 2018-2027
8.2.5 Gene Editing Technology Market Size and Forecast by Cell Lines & Engineering, 2018-2027
8.2.6 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027
8.3 Gene Editing Technology Market Share by TALENs Product (%), 2018-2027
8.3.1 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027
8.3.2 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027
8.3.3 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027
8.4 Gene Editing Technology Market Share by ZFNs Product (%), 2018-2027
8.4.1 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027
8.4.2 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027
8.4.3 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027
8.5 Gene Editing Technology Market Share by Meganucleases Product (%), 2018-2027
8.5.1 Gene Editing Technology Market Size and Forecast by Kits & Enzymes, 2018-2027
8.5.2 Gene Editing Technology Market Size and Forecast by Cell lines & Antibodies, 2018-2027
8.5.3 Gene Editing Technology Market Size and Forecast by Others (Plasmid, Controls), 2018-2027
8.6 Gene Editing Technology Market Share by Delivery Mode (%), 2018-2027
8.6.1 Gene Editing Technology Market Size and Forecast by Ex-vivo, 2018-2027
8.6.2 Gene Editing Technology Market Size and Forecast by In-vivo, 2018-2027
8.7 Gene Editing Technology Market Share by Disease/Disorders (%), 2018-2027
8.7.1 Gene Editing Technology Market Size and Forecast by Cancer, 2018-2027
8.7.2 Gene Editing Technology Market Size and Forecast by Blood Disorders, 2018-2027
8.7.3 Gene Editing Technology Market Size and Forecast by Blindness, 2018-2027
8.7.4 Gene Editing Technology Market Size and Forecast by Respiratory Disease, 2018-2027
8.7.5 Gene Editing Technology Market Size and Forecast by Others, 2018-2027
8.8 Gene Editing Technology Market Share by Application (%), 2018-2027
8.8.1 Gene Editing Technology Market Size and Forecast by Drug Development, 2018-2027
8.8.2 Gene Editing Technology Market Size and Forecast by Diagnostics, 2018-2027
8.8.3 Gene Editing Technology Market Size and Forecast by Plant Gene Editing, 2018-2027
8.8.4 Gene Editing Technology Market Size and Forecast by Animal Gene Editing, 2018-2027
8.9 Gene Editing Technology Market Share by End User (%), 2018-2027
8.9.1 Gene Editing Technology Market Size and Forecast by Pharmaceutical and Biopharmaceutical Companies, 2018-2027
8.9.2 Gene Editing Technology Market Size and Forecast by Biotechnology Companies, 2018-2027
8.9.3 Gene Editing Technology Market Size and Forecast by Contract Research Organisations, 2018-2027
8.9.4 Gene Editing Technology Market Size and Forecast by Academic Institutes and Research Centres, 2018-2027
Chapter 9- Chapter 39: This section contains chapters providing gene editing market sizing and forecast for additional 21 countries and 6 regions.
This report includes 1091 tables across various sections covering global, regional, and country level analysis. Due to space constraints, limited number of tables have been displayed here.
Table 1: Gene Editing Technology Financial Deals Market Size and Forecast, by Value (USD Million), 2018-2027
Table 2: Gene Editing Technology Funding and Investment by Value (USD Million), 2018-2027
Table 3: Recent list of CRISPR Technology Patents
Table 4: Recent list of TALENs Technology Patents
Table 5: Recent list of ZFN Technology Patents
Table 6: Recent list of Meganucleases Technology Patents
Table 7: Gene Editing Technology Market Size by Value (USD Million), 2018-2027
Table 8: Gene Editing Technology Market Size by CRISPR by Value (USD Million), 2018-2027
Table 9: Gene Editing Technology Market Size by TALENs by Value (USD Million), 2018-2027
Table 10: Gene Editing Technology Market Size by ZFNs by Value (USD Million), 2018-2027
Table 11: Gene Editing Technology Market Size by Meganucleases by Value (USD Million), 2018-2027
Table 12: Gene Editing Technology Market Size by Vector Based Cas9 by Value (USD Million), 2018-2027
Table 13: Gene Editing Technology Market Size by DNA Free Cas9 by Value (USD Million), 2018-2027
Table 14: Gene Editing Technology Market Size by Libraries & Antibodies by Value (USD Million), 2018-2027
Table 15: Gene Editing Technology Market Size by gRNA Design and Vector Construction by Value (USD Million), 2018-2027
Table 16: Gene Editing Technology Market Size by Cell Lines & Engineering by Value (USD Million), 2018-2027
Table 17: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Table 18: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027
Table 19: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027
Table 20: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Table 21: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027
Table 22: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027
Table 23: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Table 24: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027
Table 25: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027
Table 26: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Table 27: Gene Editing Technology Market Size by Ex-vivo by Value (USD Million), 2018-2027
Table 28: Gene Editing Technology Market Size by In-vivo by Value (USD Million), 2018-2027
Table 29: Gene Editing Technology Market Size by Cancer by Value (USD Million), 2018-2027
Table 30: Gene Editing Technology Market Size by Blood Disorders by Value (USD Million), 2018-2027
Table 31: Gene Editing Technology Market Size by Blindness by Value (USD Million), 2018-2027
Table 32: Gene Editing Technology Market Size by Respiratory Disease by Value (USD Million), 2018-2027
Table 33: Gene Editing Technology Market Size by Others by Value (USD Million), 2018-2027
Table 34: Gene Editing Technology Market Size by Drug Development by Value (USD Million), 2018-2027
Table 35: Gene Editing Technology Market Size by Diagnostics by Value (USD Million), 2018-2027
Table 36: Gene Editing Technology Market Size by Plant Gene Editing by Value (USD Million), 2018-2027
Table 37: Gene Editing Technology Market Size by Animal Gene Editing by Value (USD Million), 2018-2027
Table 38: Gene Editing Technology Market Size by Pharmaceutical and Biopharmaceutical Companies by Value (USD Million), 2018-2027
Table 39: Gene Editing Technology Market Size by Biotechnology Companies by Value (USD Million), 2018-2027
Table 40: Gene Editing Technology Market Size by Contract Research Organisations by Value (USD Million), 2018-2027
Table 41: Gene Editing Technology Market Size by Academic Institutes and Research Centres by Value (USD Million), 2018-2027
Table 42 - 1091: For more information, please contact us on info@biointel360.com
This report includes 1467 figures across various sections covering global, regional, and country-level analysis. Due to space constraints, the limited number of figures have been displayed here.
Figure 1: BioIntel360's Research Methodology
Figure 2: Historical Events: Gene Editing Technology
Figure 3: CRISPR Based: Cancer Therapeutics Discovery and Clinical Pipeline
Figure 4: CRISPR Based: Blood Therapeutics Discovery and Clinical Pipeline
Figure 5: CRISPR Based: Blood Therapeutics Discovery and Clinical Pipeline
Figure 6: CRISPR Based: Bacterial Infection Therapeutics Discovery and Clinical Pipeline
Figure 7: CRISPR Based: Eye Therapeutics Discovery and Clinical Pipeline
Figure 8: TALENs Based: Cancer Therapeutics Discovery and Clinical Pipeline
Figure 9: ZFNs Based: Metabolic Disorders Therapeutics Discovery and Clinical Pipeline
Figure 10: Meganucleases Based: Cancer Therapeutics Discovery and Clinical Pipeline
Figure 11: Gene Editing Technology Financial Deals Market Size and Forecast, by Value (USD Million), 2018-2027
Figure 12: Global Gene Editing - Partnership Vs Mergers & Acquisition Analysis, 2021 vs 2024
Figure 13: Global Gene Editing Financial Deals - Analysis by Application, 2021 vs 2024
Figure 14: Global Gene Editing Financial Deals - Analysis by Diseases, 2021 vs 2024
Figure 15: Global Gene Editing Financial Deals - Analysis by Region, 2021 vs 2024
Figure 16: Global Gene Editing Financial Deals - Analysis by Technology, 2021 vs 2024
Figure 17: Global Gene Editing Financial Deals - Analysis by End Users, 2017 vs 2024
Figure 18: Gene Editing Technology Funding and Investment annually analysis, by Value (USD Million), 2018-2027
Figure 19: Gene Editing Technology Funding and Investment, by Year Growth Rate (%) 2018-2027
Figure 20: Gene Editing Technology Funding and Investment, by Geographical Regions 2021 vs 2024
Figure 21: Gene Editing Technology Funding and Investment, by Type of Industry Players, 2021 vs 2024
Figure 22: Gene Editing Technology Funding and Investment, by Therapeutics, 2021 vs 2024
Figure 23: Gene Editing Technology Funding Analysis, by Type of Funding, 2021
Figure 24: Recent List of Major Acquisitions and Mergers
Figure 25: Recent North America Region Financial Deals/Partnerships
Figure 26: Recent European Region Financial Deals/Partnerships
Figure 27: Gene Editing Technology Historical and Futuristic Trend - Patent Granted 2018-2027
Figure 28: Patent Distribution by Industry Players and Non-Industry Players
Figure 29: Gene Editing Technology CPC Code White Space Analysis
Figure 30: Gene Editing Technology CRISPR Keyword Search Expressions
Figure 31: Gene Editing Technology TALENs Keyword Search Expressions
Figure 32: Gene Editing Technology ZFNs Keyword Search Expressions
Figure 33: Gene Editing Technology Patent Analysis by Type of Innovation, 2021
Figure 34: Gene Editing Technology Type of Innovation Futuristics Analysis, 2021 vs 2024
Figure 35: Gene Editing Technology - Massachusetts Institute of Technology and their CPC classification code analysis
Figure 36: Gene Editing Technology - The Broad Institute INC and their CPC classification code analysis
Figure 37: Gene Editing Technology - President and Fellows of Harvard College and their CPC classification code analysis
Figure 38: Gene Editing Technology - Howard Hughes Medical Institute and their CPC classification code analysis
Figure 39: Gene Editing Technology - The Brigham and Women's Hospital INC and their CPC classification code analysis
Figure 40: Gene Editing Technology - Benson Hill Seeds INC and their CPC classification code analysis
Figure 41: Gene Editing Technology - Sakata Seed Corporation and their CPC classification code analysis
Figure 42: Gene Editing Technology - Massachusetts Institute of Technology and their CPC classification code analysis
Figure 43: Gene Editing Technology - Hmclause INC and their CPC classification code analysis
Figure 44: Gene Editing Technology - Corteva Agriscience LLC and their CPC classification code analysis
Figure 45: Gene Editing Technology - Sangamo Therapeutics INC and their CPC classification code analysis
Figure 46: Gene Editing Technology - Hmclause INC and their CPC classification code analysis
Figure 47: Gene Editing Technology - Regeneron Pharmaceuticals INC and their CPC classification code analysis
Figure 48: Gene Editing Technology - Regents of the University of California and their CPC classification code analysis
Figure 49: Gene Editing Technology - University of Massachusetts and their CPC classification code analysis
Figure 50: Gene Editing Technology - Patent Valuation Analysis
Figure 51: Gene Editing Technology - Patent Documents Comparison Based on Parameters
Figure 52: Most Valuable Patent Examples
Figure 53: Gene Editing Technology - Scope of Innovation Analysis
Figure 54: Gene Editing Technology FTO Analysis Based on Scope of Innovation
Figure 55: Gene Editing - CRISPR Patent Trends Associated with Legal Status 2017-2022
Figure 56: Gene Editing - TALENs Patent Trends Associated with Legal Status 2017-2022
Figure 57: Gene Editing - ZFNs Patent Trends Associated with Legal Status 2017-2022
Figure 58: Gene Editing - Meganucleases Patent Trends Associated with Legal Status 2017-2022
Figure 59: Gene Editing - CRISPR Technology Patent Published Status Analysis, 2017-2022
Figure 60: Gene Editing - TALENs Technology Patent Published Status Analysis, 2017-2022
Figure 61: Gene Editing - ZFNs Technology Patent by Published Status Analysis, 2017-2022
Figure 62: Gene Editing - Meganucleases Technology Patent by Published Status Analysis, 2017-2022
Figure 63: Gene Editing - CRISPR Technology Patent by Investors Analysis, 2017-2022
Figure 64: Gene Editing - TALENs Technology Patent by Investors Analysis, 2017-2022
Figure 65: Gene Editing - ZFNs Technology Patent by Investors Analysis, 2017-2022
Figure 66: Gene Editing - Meganucleases Technology Patent by Investors Analysis, 20217-2022
Figure 67: Gene Editing - CRISPR Technology Patent by Top Applicants Analysis, 2017-2022
Figure 68: Gene Editing - TALENs Technology Patent by Top Applicants Analysis, 2017-2022
Figure 69: Gene Editing - ZFNs Technology Patent by Top Applicants Analysis, 2017-2022
Figure 70: Gene Editing - Meganucleases Technology Patent by Top Applicants Analysis, 2017-2022
Figure 71: Gene Editing - CRISPR Technology Patent Top CPC Classification Code, 2017-2022
Figure 72: Gene Editing - TALENs Technology Patent Top CPC Classification Code, 2017-2022
Figure 73: Gene Editing - ZFNs Technology Patent Top CPC Classification Code, 2017-2022
Figure 74: Gene Editing - Meganucleases Technology Patent Top CPC Classification Code, 2017-2022
Figure 75: Gene Editing - CRISPR Technology Patent Documents by Jurisdiction, 2017-2022
Figure 76: Gene Editing - TALENs Technology Patent Documents by Jurisdiction, 2017-2022
Figure 77: Gene Editing - ZFNs Technology Patent Documents by Jurisdiction, 2017-2022
Figure 78: Gene Editing - Meganucleases Technology Patent Documents by Jurisdiction, 2017-2022
Figure 79: Gene Editing - Clinical Trial Region-wise Forecast Analysis, 2017-2027
Figure 80: Gene Editing - CRISPR Clinical Trial Country-wise Analysis
Figure 81: Gene Editing - TALENs Clinical Trial Country-wise Analysis
Figure 82: Gene Editing - ZFNs Clinical Trial Country-wise Analysis
Figure 83: Gene Editing - CRISPR Clinical Trial Disease-wise Analysis, 2021 vs 2024
Figure 84: Gene Editing - TALENs Clinical Trial Disease-wise Analysis, 2021 vs 2024
Figure 85: Gene Editing - ZFNs Clinical Trial Disease-wise Analysis, 2021 vs 2024
Figure 86: Gene Editing - CRISPR Clinical Trial Phase-wise Analysis, 2021 vs 2024
Figure 87: Gene Editing - TALENs Clinical Trial Phase-wise Analysis, 2021 vs 2024
Figure 88: Gene Editing - ZFNs Clinical Trial Phase-wise Analysis, 2021 vs 2024
Figure 89: Gene Editing - CRISPR Clinical Trial Status Analysis
Figure 90: Gene Editing - TALENs Clinical Trial Status Analysis
Figure 91: Gene Editing - ZFNs Clinical Trial Status Analysis
Figure 92: Gene Editing - CRISPR Clinical Trial Study-type Analysis
Figure 93: Gene Editing - TALENs Clinical Study-type Analysis
Figure 94: Gene Editing - ZFNs Clinical Study-type Analysis
Figure 95: Recent CRISPR Clinical Trial List
Figure 96: Recent TALENs Clinical Trial List
Figure 97: Recent ZFNs Clinical Trial List
Figure 98: Gene Editing Technology Companies Competitive Landscape
Figure 99: Gene Editing Technology Companies Mapping Quadrant
Figure 100: Gene Editing Technology Companies by End Users
Figure 101: Gene Editing Technology Companies by Geography
Figure 102: Gene Editing Technology Companies by Different Technology
Figure 103: Gene Editing Technology Companies by Market Domain
Figure 104: Gene Editing Technology Market Size by Value (USD Million), 2018-2027
Figure 105: Gene Editing Technology Market Share by Technology (%), 2018-2027
Figure 106: Gene Editing Technology Market Size by CRISPR by Value (USD Million), 2018-2027
Figure 107: Gene Editing Technology Market Size by TALENs by Value (USD Million), 2018-2027
Figure 108: Gene Editing Technology Market Size by ZFNs by Value (USD Million), 2018-2027
Figure 109: Gene Editing Technology Market Size by Meganucleases by Value (USD Million), 2018-2027
Figure 110: Gene Editing Technology Market Share by CRISPR Product (%), 2018-2027
Figure 111: Gene Editing Technology Market Size by Vector Based Cas9 by Value (USD Million), 2018-2027
Figure 112: Gene Editing Technology Market Size by DNA Free Cas9 by Value (USD Million), 2018-2027
Figure 113: Gene Editing Technology Market Size by Libraries & Antibodies by Value (USD Million), 2018-2027
Figure 114: Gene Editing Technology Market Size by gRNA Design and Vector Construction by Value (USD Million), 2018-2027
Figure 115: Gene Editing Technology Market Size by Cell Lines & Engineering by Value (USD Million), 2018-2027
Figure 116: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Figure 117: Gene Editing Technology Market Share by TALENs Product (%), 2018-2027
Figure 118: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027
Figure 119: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027
Figure 120: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Figure 121: Gene Editing Technology Market Share by ZFNs Product (%), 2018-2027
Figure 122: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027
Figure 123: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027
Figure 124: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Figure 125: Gene Editing Technology Market Share by Meganucleases Product (%), 2018-2027
Figure 126: Gene Editing Technology Market Size by Kits & Enzymes by Value (USD Million), 2018-2027
Figure 127: Gene Editing Technology Market Size by Cell lines & Antibodies by Value (USD Million), 2018-2027
Figure 128: Gene Editing Technology Market Size by Others (Plasmid, Controls) by Value (USD Million), 2018-2027
Figure 129: Gene Editing Technology Market Share, By Delivery Mode, 2018-2027
Figure 130: Gene Editing Technology Market Size by Ex-vivo by Value (USD Million), 2018-2027
Figure 131: Gene Editing Technology Market Size by In-vivo by Value (USD Million), 2018-2027
Figure 132: Gene Editing Technology Market Share by Diseases/Disorders (%), 2018-2027
Figure 133: Gene Editing Technology Market Size by Cancer by Value (USD Million), 2018-2027
Figure 134: Gene Editing Technology Market Size by Blood Disorders by Value (USD Million), 2018-2027
Figure 135: Gene Editing Technology Market Size by Blindness by Value (USD Million), 2018-2027
Figure 136: Gene Editing Technology Market Size by Respiratory Disease by Value (USD Million), 2018-2027
Figure 137: Gene Editing Technology Market Size by Others by Value (USD Million), 2018-2027
Figure 138: Gene Editing Technology Market Share by Applications (%), 2018-2027
Figure 139: Gene Editing Technology Market Size by Drug Development by Value (USD Million), 2018-2027
Figure 140: Gene Editing Technology Market Size by Diagnostics by Value (USD Million), 2018-2027
Figure 141: Gene Editing Technology Market Size by Plant Gene Editing by Value (USD Million), 2018-2027
Figure 142: Gene Editing Technology Market Size by Animal Gene Editing by Value (USD Million), 2018-2027
Figure 143: Gene Editing Technology Market Share by End Users (%), 2018-2027
Figure 144: Gene Editing Technology Market Size by Pharmaceutical and Biopharmaceutical Companies by Value (USD Million), 2018-2027
Figure 145: Gene Editing Technology Market Size by Biotechnology Companies by Value (USD Million), 2018-2027
Figure 146: Gene Editing Technology Market Size by Contract Research Organisations by Value (USD Million), 2018-2027
Figure 147: Gene Editing Technology Market Size by Academic Institutes and Research Centres by Value (USD Million), 2018-2027
Figure 148 - 1467: For more information, please contact us on info@biointel360.com
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security